A Randomized Study of the Effect of Withdrawing Hydroxychloroquine Sulfate in Systemic Lupus Erythematosus
Open Access
- 17 January 1991
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 324 (3) , 150-154
- https://doi.org/10.1056/nejm199101173240303
Abstract
The antimalarial drug hydroxychloroquine is thought to be effective in controlling some of the manifestations of systemic lupus erythematosus, but its effectiveness has not been demonstrated conclusively. Methods. We conducted a six-month, randomized,Keywords
This publication has 19 references indexed in Scilit:
- The relationship of socioeconomic status to subsequent health status in systemic lupus erythematosusArthritis & Rheumatism, 1988
- THE PRESCRIBING OF CHLOROQUINE AND HYDROXYCHLOROQUINE BY CONSULTANT RHEUMATOLOGISTS IN THE UKRheumatology, 1987
- Antimalarial drugs for rheumatoid arthritisThe American Journal of Medicine, 1983
- Risk/benefit analysis of hydroxychloroquine sulfate treatment in rheumatoid arthritisThe American Journal of Medicine, 1983
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- The arthritis impact measurement scales. further investigations of a health status measureArthritis & Rheumatism, 1982
- Ophthalmologic safety of long‐term hydroxychloroquine treatmentArthritis & Rheumatism, 1979
- Quinacrine in the Treatment of Discoid Lupus Erythematosus: A Five Year Follow-Up Survey — Results and EvaluationSouthern Medical Journal, 1959
- Observations on the course and treatment of systemic lupus erythematosusArthritis & Rheumatism, 1958
- TREATMENT OF LUPUS ERYTHEMATOSUS WITH MEPACRINE. Results and Relapses during a long Observation.British Journal of Dermatology, 1956